This site is intended for health professionals only
Thursday 21 September 2017
Share |

Tivozanib now licensed in the European Union for first-line treatment

EUSA Pharma has announced that the European Commission (EC) has licensed Fotivda® for the management of adult patients with advanced renal cell carcinoma (RCC) in the European Union plus Norway and Iceland.

Ads by Google